Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies

Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies

US Patent 10683347 · Granted Jun 16, 2020

Estimated economic value: $3,098,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that bind interleukin-2 and uses thereof2025
Antibodies that bind interleukin-2 and uses thereof2025
Antibodies that bind transforming growth factor beta (TGF beta) and methods of u2024
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2023
Method of increasing the ratio of effector T cells to regulatory T cells in a tu2023
Method of increasing the ratio of effector T cells to regulatory T cells in a tu2023
Method of increasing the ratio of effector T cells to regulatory T cells in a tu2023
Anti-AVB8 antibodies and compositions and uses thereof2022
Method of treating cancer by administering an antibody that binds transforming g2021
Antibodies that bind interleukin-2 and uses thereof2020
Antibodies that bind interleukin-2 and uses thereof2020
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2019